A database(information stored in electronic format) of blood cancer patients, in which all the information related disease and treatment will be collected and stored.
Not Applicable
- Conditions
- Health Condition 1: C940- Acute erythroid leukemiaHealth Condition 2: C950- Acute leukemia of unspecified celltypeHealth Condition 3: C910- Acute lymphoblastic leukemia [ALL]Health Condition 4: C942- Acute megakaryoblastic leukemiaHealth Condition 5: C930- Acute monoblastic/monocytic leukemiaHealth Condition 6: C920- Acute myeloblastic leukemia
- Registration Number
- CTRI/2020/02/023455
- Lead Sponsor
- ot Applicable
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
-Newly-diagnosed leukemia
-Signed written informed consent
-Age more than or equal to 15 years
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3- Year overall survivalTimepoint: At 3 year
- Secondary Outcome Measures
Name Time Method 1.Epidemiology <br/ ><br>2.complete remission (CR) and CRm <br/ ><br>3.Minimal residual disease negative status post therapy <br/ ><br>4.Treatment related mortality (TRM) <br/ ><br>5.Cumulative incidence of relapse (CIR) <br/ ><br>6.Relapse free survival <br/ ><br>7.Grade IV toxicities <br/ ><br>8.Pattern of infections <br/ ><br>9.Quality of life (QoL)assessmentTimepoint: 1.Epidemiology-5 year <br/ ><br>2.complete remission (CR) and CRm-30 days <br/ ><br>3.Minimal residual disease negative status post therapy-30 days <br/ ><br>4.Treatment related mortality (TRM)-30 days <br/ ><br>5.Cumulative incidence of relapse (CIR)-3 years <br/ ><br>6.Relapse free survival-3 years <br/ ><br>7.Grade IV toxicities-30 days <br/ ><br>8.Pattern of infections-30 days <br/ ><br>9.Quality of life (QoL)assessment- every year